** Cancer therapy maker Legend Biotech's LEGN.O shares rise 5.6% to $35.96
** Co posts Q4 adj. net loss of 16 cents per share, compared to a loss of 24 cents per share a year earlier
** Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which co believes will provide financial runway into Q2 2026
** LEGN has fallen 46.1% in the past 12 months
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。